Final answer:
Acetazolamide is used to treat chronic open-angle glaucoma by competitively inhibiting the carbonic anhydrase enzyme, and reducing intraocular pressure.
Step-by-step explanation:
Chronic open-angle glaucoma is treated with acetazolamide, a medication that inhibits the enzyme carbonic anhydrase. This inhibition is competitive, meaning it temporarily blocks the enzyme's active site, thus reducing the formation of water within the eye. By decreasing aqueous humor production, it lowers intraocular pressure, helping to manage glaucoma symptoms and prevent vision loss.
The choice of treatment depends on various factors, including the severity of the glaucoma, the response to medications, and the patient's overall health. Individuals with glaucoma need to have regular eye examinations and follow the prescribed treatment plan to manage the condition effectively and prevent vision loss. The specific treatment plan is determined by an ophthalmologist based on the individual's case.